Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
Objective To explore independent influencing factors for clinical efficacy of roxadustat in hemodialysis patients.Methods Hemodialysis patients treated with roxadustat were enrolled. The plasma trough concentrations of roxadustat were measured using liquid chromatography–tandem mass spectrometry (LC...
Saved in:
Main Authors: | Wenhui Wu, Nan Hu, Xiurong Li, Jia Di, Hua Zhou, Hongyan Niu, Min Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2308701 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
by: Lei Tian, et al.
Published: (2024-12-01) -
Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
by: Tingting Fang, et al.
Published: (2025-02-01) -
Mitophagy mediated by HIF-1α/FUNDC1 signaling in tubular cells protects against renal ischemia/reperfusion injury
by: Wenjun Zhang, et al.
Published: (2024-12-01) -
Efficacy of Intravenous Versus Oral Administration of Levocarnitine in Maintenance Hemodialysis Patients: A Randomized Controlled Trial Investigating Therapeutic Approaches to Renal Anemia
by: Sadia Rehman, et al.
Published: (2025-01-01) -
On the enhancement of the efficiency of concentrated solar power plants using nanofluids based on a linear silicone fluid and Pt nanoparticles
by: Juan Jesús Gallardo, et al.
Published: (2025-01-01)